Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bioceres Crop Solutions (BIOX)
NASDAQ:BIOX
RESEARCH TOOLSreports
Holding BIOX?
Track your performance easily
BIOX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.71 - $14.05
Previous Close$6.19
Volume100.87K
Average Volume (3M)194.52K
Market Cap
$389.06M
Enterprise Value$641.38M
Total Cash (Recent Filing)$54.18M
Total Debt (Recent Filing)$270.95M
Price to Earnings (P/E)275.1
Beta0.54
Next Earnings
Feb 06, 2025EPS Estimate
$0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding62,848,483
10 Day Avg. Volume278,189
30 Day Avg. Volume194,520
Standard Deviation0.13
R-Squared0.05
Alpha0.00454
Financial Highlights & Ratios
Price to Book (P/B)1.30
Price to Sales (P/S)1.76
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.90
Enterprise Value/Gross Profit3.44
Enterprise Value/Ebitda23.89
Forecast
1Y Price Target
$11.83Price Target Upside91.11% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Bioceres Crop Solutions News
PremiumCompany Announcements
Bioceres Crop Solutions’ Subsidiary Completes $25.9M Bond Offering
PremiumCompany Announcements
Bioceres Crop Solutions Financial Update
PremiumCompany Announcements
Bioceres Crop Solutions Reports Q1 2025 Financial Results
PremiumCompany Announcements
Bioceres Crop Solutions: Resilience in Fiscal First Quarter
Bulls Say, Bears Say
Bulls Say
Geographical And Product DiversificationBioceres benefitted from both geographical and product diversification, mitigating some revenue losses and receiving positive contributions from Brazil, the United States and from the Sygenta collaboration agreement outside of Argentina.
GMO Wheat DemandAs the HB4 sales channel solidifies and Bioceres finalizes a distribution partner for it, GMO wheat demand should enhance the company’s margin profile over time.
Valuation OpportunityBioceres is considered undervalued compared to its peers, making it a potential opportunity for value investors.
Bears Say
Financial PerformanceRevenue of $93M fell below the $105M estimate and well below the prior year’s $117M figure, primarily due to dry conditions in Argentina.
Market OutlookPoor field conditions have led to a downward revision of Bioceres’ Q1 estimates, impacting the full-year outlook.
Product PerformanceExpectations for Bioceres’ drought resistant HB4 soy/wheat have been reset downwards following previous disappointments, affecting the stock's potential.
---
Ownership Overview
―
Insiders
0.57% Mutual Funds
18.88% Other Institutional Investors
78.88% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BIOX FAQ
What was Bioceres Crop Solutions’s price range in the past 12 months?
Bioceres Crop Solutions lowest stock price was $5.71 and its highest was $14.05 in the past 12 months.
What is Bioceres Crop Solutions’s market cap?
Currently, no data Available
When is Bioceres Crop Solutions’s upcoming earnings report date?
Bioceres Crop Solutions’s upcoming earnings report date is Feb 06, 2025 which is in 46 days.
How were Bioceres Crop Solutions’s earnings last quarter?
Bioceres Crop Solutions released its earnings results on Nov 12, 2024. The company reported -$0.084 earnings per share for the quarter, missing the consensus estimate of -$0.022 by -$0.062.
Is Bioceres Crop Solutions overvalued?
According to Wall Street analysts Bioceres Crop Solutions’s price is currently Undervalued.
Does Bioceres Crop Solutions pay dividends?
Bioceres Crop Solutions does not currently pay dividends.
What is Bioceres Crop Solutions’s EPS estimate?
Bioceres Crop Solutions’s EPS estimate is $0.15.
How many shares outstanding does Bioceres Crop Solutions have?
Bioceres Crop Solutions has 62,852,710 shares outstanding.
What happened to Bioceres Crop Solutions’s price movement after its last earnings report?
Bioceres Crop Solutions reported an EPS of -$0.084 in its last earnings report, missing expectations of -$0.022. Following the earnings report the stock price went up 2.778%.
Which hedge fund is a major shareholder of Bioceres Crop Solutions?
Among the largest hedge funds holding Bioceres Crop Solutions’s share is Ardsley Advisory Partners. It holds Bioceres Crop Solutions’s shares valued at 12M.
---
Bioceres Crop Solutions Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$11.83 (91.11% Upside)
$11.83 (91.11% Upside)
Blogger Sentiment
Bullish
BIOX Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 172.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.5%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-54.51%
12-Months-Change
Fundamentals
Return on Equity
0.50%
Trailing 12-Months
Asset Growth
0.92%
Trailing 12-Months
Company Description
Bioceres Crop Solutions
Union Acquisition Corp. is a blank check company, which engages in the provision of merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was founded on November 14, 2017 and is headquartered in New York, NY.
---
BIOX Company Deck
---
BIOX Earnings Call
Q1 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed performance for Bioceres. While there are significant achievements in international market growth, regulatory approvals, and cash management, the company faced challenges with revenue decline due to weather conditions in Argentina and a substantial drop in corn acreage. Overall, the sentiment is balanced as the company navigates both positive international trends and domestic challenges.Read More>---
BIOX Stock 12 Month Forecast
Average Price Target
$11.83
▲(91.11% Upside)
Technical Analysis
Best Analysts Covering BIOX
1 Year
1 Year Success Rate
16/36 ratings generated profit
1 Year Average Return
+20.57%
assigned a buy rating last month
Copying Ben Klieve's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of +20.57% per trade.
---